Clive Richardson: CEO of Akari Therapeutics

Portrait of Clive Richardson

BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics  is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene  pathways

Acme United Annual Report detail
Acme United

Cutting Edge Technology

Shionogi

An Opportunity Pipeline

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom